BioMara positions seaweed-derived ingredient for gut health
The UK-based seaweed processing enterprise has accomplished commercial-scale trials of its proprietary fucoidan extraction course of on the bioprocessing facility Centre for Course of Innovation (CPI)—a key step in bringing Thalivra to market. The trials started with 500-liter...